Rita A. Karachun - 01 May 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Sr. VP Fince-Global Controller
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Rita Karachun
Issuer symbol
MRK
Transactions as of
01 May 2023
Transactions value $
$70,552
Form type
4
Filing time
03 May 2023, 16:24:55 UTC
Previous filing
25 Jan 2023
Next filing
04 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $107K +930 +2.12% $115.47 44.9K 01 May 2023 Direct
transaction MRK Common Stock Tax liability -$36.8K -319 -0.71% $115.47 44.6K 01 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -930 -100% $0.00* 0 01 May 2023 Common Stock 930 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.